Terms ending in 2038
Every in-force patent on CureVac AG's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,371,699 | Nucleic Acids Encoding CRISPR-Associated Proteins and Uses Thereof In force · High confidence | CureVac SE | In force | High confidence | |
| US 12,533,422 | Modified RNA with Decreased Immunostimulatory Properties In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,602,557 | Bunyavirales Vaccine In force · High confidence | Curevac SE | In force | High confidence | |
| US 12,397,048 | Bunyavirales Vaccine In force · Medium confidence | CureVac SE | In force | Medium confidence | |
| US 12,649,914 | Method of RNA in Vitro Transcription Using a Buffer Containing a Dicarboxylic Acid or Tricarboxylic Acid or a Salt Thereof In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,542,490 | RNAs for Wound Healing In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,524,066 | Henipavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,692,002 | RNA Sequence Adaptation In force · High confidence | Curevac SE | In force | High confidence | |
| US 12,569,549 | Flavivirus Vaccine In force · High confidence | Sanofi R&D Vaccins | In force | High confidence | |
| US 11,525,158 | Linear Double Stranded DNA Coupled to a Single Support or a Tag and Methods for Producing Said Linear Double Stranded DNA In force · High confidence | Curevac SE | In force | High confidence | |
| 2 more term ends in 2038 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
11 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.